“…Various mathematical models to characterize in vitro viral dynamics (Bagheri et al, 2011;Titze et al, 2017), in vivo behavior limited to tumor size metrics (Bajzer et al, 2008;Eftimie et al, 2011), theoretical frameworks (Wein et al, 2003;Mok et al, 2009;Paiva et al, 2009;Malinzi et al, 2017;Jenner et al, 2018;Cassidy and Humphries, 2019;Al-Tuwairqi et al, 2020) and develop predictive in-silico trials (Jenner et al, 2021) have been so far described. To the best of our knowledge, the integration of kinetic parameters including viral distribution to tumor lesions and comparing i. t. and i. v. administrations has not yet been addressed.…”